Percutaneous Edge-to-Edge Mitral Valve Repair for Functional Mitral Regurgitation
Wong Ningyan,Yeo Khung Keong +1 more
6
TL;DR: An overview of the current understanding on the role of Transcatheter edge-to-edge repair of the mitral valve in FMR is provided as well as the 2 landmark randomized controlled trials providing deep insights on patient selection.
read more
Abstract: The presence and severity of functional mitral regurgitation (FMR) is associated with worse outcomes in patients with heart failure and reduced ejection fraction. Prior to the availability of percutaneous mitral valve repair, management for FMR has been limited to medical therapy, cardiac resynchronization therapy for a specific subset of patients and surgery which has yet to demonstrate mortality benefits. Transcatheter edge-to-edge repair (TEER) of the mitral valve has emerged in the past decade as an invaluable member of the armamentarium against FMR with the 2 landmark randomized controlled trials providing deep insights on patient selection. In addition, TEER has spurred the rapid advancement in our understanding of FMR. This article seeks to provide an overview as well as our current understanding on the role of TEER in FMR.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
A importância da abordagem clínica e terapêutica para manejo e tratamento da insuficiência cardíaca avançada
Andréa Lemos,Bertha de Queiroz Camillo,Elane Cristina Magalhães Alves,Laís Ferreira Carrijo,Levi de Albuquerque Lopes Cavalcante,María Aparecida Vieira,Maria Sílvia da Fonseca e Silva Levy,Murilo Adolfo Fernandes +7 more
- 01 Jan 2024
TL;DR: A insuficiência cardíaca avançada apresenta desafios para o tratamento clínico, com baixa resposta à terapia e alto risco de hospitalizações e morte.
A importância da abordagem clínica e terapêutica para manejo e tratamento da insuficiência cardíaca avançada
Andréa Lemos,Bertha de Queiroz Camillo,Elane Cristina Magalhães Alves,Laís Ferreira Carrijo,Levi de Albuquerque Lopes Cavalcante,María Aparecida Vieira,M.S. Silva,Lígia de Souza Fernandes +7 more
- 01 Jan 2024
TL;DR: A insuficiência cardíaca avançada apresenta desafios para o tratamento clínico, com baixa resposta à terapia e alto risco de hospitalizações e morte.
Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy
С. А. Будагаев,Maksat Zhakayev,Rustem M. Tuleutayev,Michel Vorontsov,Artem Nikitenko,Zhanar Nurbay,Daniyar Kunapyanov,M. Pashimov +7 more
TL;DR: Mitral valve repair during septal myectomy in obstructive hypertrophic cardiomyopathy is a procedure that eliminates obstruction at all levels of the left ventricular outflow tract and can significantly improve hemodynamic function.
Advanced heart failure: a contemporary approach.
Kyeong Hyeon Chun,Seok Min Kang +1 more
TL;DR: The role of implantable cardioverter-defibrillators in advanced heart failure patients requires further investigation considering the introduction of novel HF medications, such as inotropic agents, while renal replacement therapy may be beneficial if necessary as mentioned in this paper .
References
The effect of cardiac resynchronization on morbidity and mortality in heart failure
John G.F. Cleland,Jean-Claude Daubert,Erland Erdmann,Nick Freemantle,Daniel Gras,Lukas Kappenberger,Luigi Tavazzi +6 more
- 14 Apr 2005
TL;DR: Cardiac resynchronization has been shown to reduce symptoms and improve left ventricular function in patients with heart failure due to systolic dysfunction and cardiac dyssynchrony.
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Helmut Baumgartner,Volkmar Falk,Jeroen J. Bax,Michele De Bonis,Christian W. Hamm,Per Johan Holm,Bernard Iung,Patrizio Lancellotti,Emmanuel Lansac,Daniel Rodriguez Muñoz,Raphael Rosenhek,Johan Sjögren,Pilar Tornos Mas,Alec Vahanian,Thomas Walther,Olaf Wendler,Stephan Windecker,José Luis Zamorano +17 more
5.7K
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Rick A. Nishimura,Catherine M Otto,Robert O. Bonow,Blase A. Carabello,John P. Erwin,Robert A. Guyton,Patrick T. O'Gara,Carlos E. Ruiz,Nikolaos J. Skubas,Paul Sorajja,Thoralf M. Sundt,James D. Thomas +11 more
TL;DR: The medical profession should play a central role in evaluating evidence related to drugs, devices, and procedures for detection, management, and prevention of disease.
4.5K
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography
William A. Zoghbi,Maurice Enriquez-Sarano,Elyse Foster,Paul A. Grayburn,Carol D. Kraft,Robert A. Levine,Petros Nihoyannopoulos,Catherine M Otto,Miguel A. Quinones,Harry Rakowski,William J. Stewart,Alan D. Waggoner,Neil J. Weissman +12 more
TL;DR: A report from the American Society of Echocardiography’s Nomenclature and Standards Committee and The Task Force on Valvular Regurgitation developed in conjunction with the American College of Cardiology EchOCardiography Committee.
4.1K
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian,Ottavio Alfieri,Felicita Andreotti,Manuel J. Antunes,Gonzalo Barón-Esquivias,Helmut Baumgartner,Michael A. Borger,Thierry Carrel,Michele De Bonis,Arturo Evangelista,Volkmar Falk,Bernard Iung,Patrizio Lancellotti,Luc Pierard,Susanna Price,Hans-Joachim Schäfers,Gerhard Schuler,Janina Stępińska,Karl Swedberg,Johanna J.M. Takkenberg,Ulrich O. von Oppell,Stephan Windecker,José Luis Zamorano,Marian Zembala +23 more
TL;DR: Guidelines summarize and evaluate all evidence available on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome.
3.9K